Drug development is among the slowest, most failure-prone processes in modern science, with about 90% of drug candidates never reaching the market. Today, artificial intelligence methods have ...

Determining the dose of a drug that is most likely to be effective and safe is a key part of any drug development programme, but is a particular challenge for drugs for rare diseases because so few ...